We are live on ! Find out more
GT

Glenview Trust Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+23.72%
3 Year Est. Return
+87.8%
5 Year Est. Return
+115.86%
10 Year Est. Return
AUM
$5.34B
AUM Growth
+$138M
Cap. Flow
+$43.4M
Cap. Flow %
0.81%
Top 10 Hldgs %
35.23%
Holding
502
New
28
Increased
178
Reduced
199
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 25.53%
2 Financials 10.12%
3 Healthcare 9.63%
4 Consumer Discretionary 6.63%
5 Consumer Staples 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDP
501
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
-1,640,832
Closed -$41.4M
IBMM
502
DELISTED
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
-330,556
Closed -$8.63M

Similar funds

Glenview Trust's Q4 2024 Portfolio in Review

As of Q4 2024, Glenview Trust held 502 positions worth $5.34B, up 2.7% from $5.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Glenview Trust's Q4 2024 filing shows 28 new, 178 increased, 199 reduced and 24 closed positions. Its largest new stake was Congress SMid Growth ETF: 642,212 shares worth $19.2M. The largest sale was iShares iBonds Dec 2024 Term Corporate ETF, an estimated $41.4M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Glenview Trust's largest Q4 2024 buy was Congress SMid Growth ETF: 642,212 shares worth $19.2M.
  • Glenview Trust added most to Boeing in Q4 2024, an estimated $19M increase.
  • Glenview Trust's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $11.2M.
  • Glenview Trust fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $41.4M.
  • Glenview Trust's ten largest holdings make up 35% of its $5.34B portfolio in Q4 2024.
  • Glenview Trust opened 28 new positions and closed 24 in Q4 2024.
  • Glenview Trust's portfolio value rose 2.7% quarter-over-quarter to $5.34B.

Based on Glenview Trust's 13F filing for Q4 2024, filed 10 Feb 2025.